X
RVMD icon

Xponance’s Revolution Medicines RVMD Stock Holding History

Xponance’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.58M Buy
40,460
+19,857
+96% +$2.9M 0.05% 292
2026
Q1 		$2M Buy
20,603
+11,777
+133% +$1.19M 0.01% 572
2025
Q4 		$703K Buy
8,826
+307
+4% +$20.1K 0.01% 799
2025
Q3 		$398K Buy
8,519
+14
+0.2% +$548 ﹤0.01% 1048
2025
Q2 		$313K Sell
8,505
-4,432
-34% -$170K ﹤0.01% 1126
2025
Q1 		$457K Buy
12,937
+810
+7% +$32.9K ﹤0.01% 963
2024
Q4 		$530K Buy
12,127
+2,140
+21% +$108K ﹤0.01% 936
2024
Q3 		$453K Buy
9,987
+336
+3% +$14.6K ﹤0.01% 969
2024
Q2 		$375K Buy
9,651
+1,175
+14% +$43.9K ﹤0.01% 991
2024
Q1 		$273K Sell
8,476
-252
-3% -$7.47K ﹤0.01% 1089
2023
Q4 		$250K Buy
+8,728
New +$210K ﹤0.01% 1102

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Xponance's RVMD Position: Q2 2026 in Review

Xponance increased its Revolution Medicines (RVMD) stake by 96% in Q2 2026, buying an estimated $2.9M and bringing the position to 40,460 shares worth $7.58M. The position accounts for 0.05% of the portfolio, ranked #292.

Xponance first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Xponance held 40,460 shares of Revolution Medicines worth $7.58M as of Q2 2026.
  • Xponance bought 19,857 Revolution Medicines shares in Q2 2026, an estimated $2.9M.
  • Revolution Medicines made up 0.05% of Xponance's portfolio in Q2 2026, its #292 holding.
  • Xponance first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.